Skip to content

Application of multi-modal MRI and high-channel sequencing technology in the therapeutic mechanism and efficacy prediction of individualized rTMS in irritable bowel syndrome

Application of multi-modal MRI and high-channel sequencing technology in the therapeutic mechanism and efficacy prediction of individualized rTMS in irritable bowel syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084428
Enrollment
Unknown
Registered
2024-05-16
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

True stimulation group:TMS stimulates individualized left dorsolateral prefrontal cortex targets
Sham stimulation group:rTMS sham stimulation

Sponsors

Affiliated Hospital of Hangzhou Normal University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Meet the Rome IV diagnostic criteria of IBS; Have stopped taking related drugs for more than 2 weeks; Aged between 18 and 59; Cognitive ability to consent to treatment, understand research instructions and questionnaires.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will be excluded from the study: have contraindications to MRI and TMS; Mental illness; Women who are pregnant, breastfeeding or preparing for pregnancy during the observation period; Signs of serious illness and/or indications of hospitalization, including hemodynamic instability, infection, acute myocardial infarction and cerebral infarction; In the past 3 months, people have taken any food (such as probiotics, prebiotics, etc.) that affects the test indicators involved in this study.

Design outcomes

Primary

MeasureTime frame
Severity of irritable bowel syndrome;Degree of depression and anxiety;Imaging indicators of brain function;

Secondary

MeasureTime frame
pain degree;quality of life ;

Countries

China

Contacts

Public ContactJie Li

Affiliated Hospital of Hangzhou Normal University

jie_sweethz@163.com+86 159 8885 8667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026